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Excessive increases in morning blood pressure (BP) upon awakening (morning BP surge: MS) has attracted interest as a potentially novel risk factor for cardiac, cerebral, renal, and vascular damage. [1] [2] [3] [4] [5] [6] [7] [8] [9] We previously reported that MS, which is defined as an excessive increase in morning systolic BP (SBP) from the lowest SBP during sleep, has been associated with the risk of cerebral infarction and cardiac hypertrophy, independent of 24-h BP levels and nocturnal BP dipping status. 1, 2 However, the available studies on MS risk have often employed divergent study populations and methodologies, which may have contributed at least in part to the discrepant results obtained. [1] [2] [3] [4] [5] [6] [7] [8] Especially, the different prevalence of drug treatment in these studies (0-30%) (refs. [1] [2] [3] [4] [5] [6] [7] [8] should be of concern, because drug treatment can exert unpredictable effects on 24-h BP profile, and thus the interpretation and applicability of these results are complex. Until now, there has been a paucity of data regarding the MS risk in elderly persons who are treated with antihypertensive medications. In order to optimize the applicability of MS to hypertensive clinical practice, it is important that studies be performed in a well-defined population of treated hypertensives during ambulatory BP monitoring (ABPM).
Therefore, the aim of this study was to assess the clinical characteristics of MS, and to evaluate the association of MS to cardiovascular remodeling, in comparison with the other BP components (24-h BP level, BP variability, and nocturnal BP decline), in treated elderly hypertensives.
methodS
From July 2007 to May 2008, 206 consecutive ambulatory patients with essential hypertension who were ≥60 years old and who had been treated at our outpatient clinic (Kitaura National Health Insurance Hospital, Miyazaki, Japan) were recruited for this study. The exclusion criteria were as follows: a history of cardiovascular diseases (coronary arterial disease and cerebrovascular disease) or heart failure in the past 3 months; presence of inflammatory diseases (acute infection, autoimmune diseases); presence of malignant diseases; atrial Background It has remained unclear whether or not morning blood pressure (BP) surge (MS) is associated with cardiovascular remodeling in elderly (≥60 years) hypertensive patients being treated by antihypertensive medications.
In this cross-sectional study (n = 197; mean 74.6 years; 37% men), we evaluated the association between MS, defined as the highest quartile of morning BP increase from sleep (≥48 mm Hg; n = 49), and extent of cardiac hypertrophy and carotid artery intima-media thickness (IMT).
reSultS
Although there were no differences in 24-h BP levels and the number of prescribed antihypertensive medications between MS and non-MS group, the use of thiazide diuretics was more frequent in MS group than non-MS group (35% vs. 19%; P < 0.05). The MS group had significantly higher levels of left ventricular mass index (LVMI) and internal-carotid artery (ICA)-IMT than the non-MS group (both P < 0.01), independent of 24-h BP levels, daytime BP variability, the degree of nocturnal BP decline, the plasma low-density lipoprotein levels, and the use of diuretics. Even in subjects with a well-controlled 24-h BP level (<130/80 mm Hg; n = 75), these relationships were similar. A multiple logistic regression analysis showed that the presence of MS was an independent determinant of LV hypertrophy (LVH) (≥125 g/m 2 in men and ≥110 g/m 2 in women) and assignment to the highest quartile of ICA-IMT (both P < 0.05).
concluSionS
The MS in subjects being treated with antihypertensive medications was significantly associated with cardiovascular remodeling, independently of 24-h BP level, daytime BP variability, and nocturnal BP decline. articles Cardiovascular Risk of Morning BP Surge fibrillation; and absence of or incomplete blood collection. None of the study subjects overlapped with those in our previous study on MS. 1, 2 This study was approved by the institutional review board at Jichi Medical University, and written informed consent was obtained from all the participants.
BP measurement. Office BP was measured by a digital oscillometric BP-monitoring device (HEM-5041; Omron Healthcare, Kyoto, Japan) with the subjects having remained seated for 5 min and calculated as the mean of three consecutive measures. ABPM (TM-2425; A&D, Tokyo, Japan) was performed with an automatic oscillometric method device at 30-min intervals during the daytime and night time. All subjects used their prescribed antihypertensive medications as usual during ABPM, and recorded their bedtime and waking time. We defined daytime and night-time BP as the average of these times. We excluded those who obtained <80% of either valid waking or sleeping BP readings (n = 4).
MS was defined in two ways 1 : (i) sleep-trough MS, defined as the highest quartile of the difference between the mean SBP during the 2 h after waking and the average of three readings centered on the lowest SBP taken while patients were asleep, and (ii) waking MS, defined as the highest quartile of the difference between the mean SBP during the 2 h after waking and the average SBP during the 2 h before waking. SBP was used for all these calculations. In this study, we subclassified the patients according to the presence of sleep-trough MS (MS group: ≥48 mm Hg, n = 49) vs. all others (non-MS group, n = 148, Table 1 ). We subclassified the patients according to the percentage of nocturnal SBP decline (100 × (1 − sleep SBP/ awake SBP)) as follows: extreme dippers if the nocturnal SBP reduction was ≥20%; dippers if the fall was ≥10% but <20%; nondippers if the fall was ≥0% but <10%; and risers if it was <0%. 10 Subjects with their 24-h BP level was <130/80 mm Hg were defined as well controlled. 10 Laboratory testing. Peripheral venous blood was obtained via a 21-gauge needle in the fasting state between 0800 and 0830 hours. Plasma was obtained by centrifuging the whole blood at 1,500 g for 15 min at 4 °C, and was immediately frozen and stored at −40 °C until analysis. The concentrations of insulin (Lumipulse Presto II; FujiRevio, Tokyo, Japan) were measured by SRL (Tokyo, Japan). The intra-assay and interassay variation coefficients of all test were <7%, respectively. Type 2 diabetes was defined as use of antihyperglycemic drugs or a fasting glucose of ≥126 mg/dl.
Cardiac and carotid ultrasonography.
A trained physician (Y.Y.) who was unaware of the patient's laboratory and ABPM data performed cardiac and carotid ultrasonography on all participants using an SSD-5000 ultrasonograph (Aloka, Tokyo, Japan). For full details, see Supplementary Methods online. Briefly, left ventricular mass index (LVMI) was calculated using the Devereux formula indexed to body surface area, and the diagnosis of LV hypertrophy (LVH) was defined as LVMI ≥125 g/m 2 in men and ≥110 g/m 2 in women. 11, 12 In repeatability analysis with 30 randomly chosen ultrasound scans, the mean difference for repeat measurements of LVMI was 8.2 ± 6.6 g/m 2 (coefficient of variation: 4.26%; coefficient of correlation: r = 0.91; P < 0.001).
The carotid arteries were examined bilaterally at the levels of the common-carotid artery (CCA), bulb, and internal-carotid artery (ICA) from transverse and longitudinal orientations. The region with the thickest intima-media thickness (IMT) was measured and included in our analysis. Focal plaques, when present, were included. ICA-IMT includes both the carotid bulb and ICA measurement, and was calculated as the mean of the single thickest point in the far wall on both sides. CCA-IMT was also calculated in the same way. A cutoff level of 1.40 mm of ICA-IMT, a prespecified value of the highest quartile of the ICA-IMT distribution, was used to classify patients into the "high" ICA-IMT group. In repeatability analysis with randomly chosen (n = 30), the mean difference for repeat measurements of ICA-IMT was 0.02 ± 0.15 mm (coefficient of variation: 9.54%; coefficient of correlation: r = 0.96; P < 0.001). The mean difference for repeat measurements of CCA-IMT was −0.04 ± 0.09 mm (coefficient of variation: 6.62%; coefficient of correlation: r = 0.98; P < 0.001).
Statistical analysis. All statistical analyses were performed with SPSS, version 16.0J software (Chicago, IL). Data are expressed as the means ± s.d. or median (25th to 75th percentile). The associations between the individual parameters were calculated using Spearman's correlation method. Our population was subdivided into quartiles according to the sleep-trough morning SBP increase, and the difference in LVMI and IMT levels was assessed using analysis of variance (ANOVA) and of covariance (ANCOVA) with controlling for significant covariates (daytime SBP variability, the degree of nocturnal BP decline, and the plasma low-density lipoprotein (LDL) level). Variables with skewed distribution were logarithmically transformed before analysis. When differences were found among the groups, Bonferroni corrections were used to make pairwise comparisons. Clinical parameters in subjects with or without MS were compared using the unpaired Student's t-test for normally distributed variables, and the Mann-Whitney U test for variables with skewed distributions. Categorical parameters were compared with the χ 2 test. The odds ratio (OR) and 95% confidence interval (CI) estimating the increased risk of LVH and highest quartile of ICA-IMT were determined by multiple logistic regression analysis. In that model, variables with a P value of ≤0.05 in a univariable association (Spearman's correlation coefficient) with LVMI and ICA-IMT were entered into the model. Statistical significance was defined as P < 0.05.
reSultS characteristics of the study population
A total of 206 patients were enrolled in our study. Two patients who refused to participate, four patients with incomplete ABPM, and three patients with unsatisfactory blood collection were excluded. Thus, 197 patients were finally included in the analysis ( Table 1) . There were no significant associations between the extent of sleep-trough morning SBP increase and the LVMI (r = 0.07, P = 0.32), ICA-IMT (r = 0.06, P = 0.44), and CCA-IMT (r = 0.13, P = 0.08). As in previous reports, 2, 4 we subdivided our population into quartiles according to the extent of the sleep-trough morning BP increase. The four groups were similar in terms of age, sex, BMI, and 24-h BP level, whereas BP variability, the degree of nocturnal BP decline, and the plasma LDL level were significantly different among the four groups (all P for trend <0.05, see Supplementary Table S1 online). The LVMI was significantly higher in patients in the highest quartile (MS group) than in patients in the lower quartile, and the ICA-IMT level was significantly higher in patients in the MS group than in patients in the lowest quartile (Figure 1) . Both associations remained significant even after adjustment for daytime SBP variability, the degree of nocturnal BP decline, and the plasma LDL level. Although there were no significant differences in the clinic as well as the 24-h BP and pulse rate levels between the MS and non-MS groups, the use of diuretics was more frequent in the MS group ( Table 1) . The prevalence of both morning and evening administration of antihypertensive drugs was the same between the two groups (8% in both groups).
cardiac ultrasonography
Compared with the non-MS group, the MS group had a significantly higher level of LVMI after adjustment for significant covariates, such as daytime SBP variability, the degree of nocturnal BP decline, the plasma LDL level, and the use of diuretics (121.3 ± 26.5 g/m 2 vs. 112.6 ± 22.2 g/m 2 ; P < 0.01). A multiple logistic regression analysis revealed that the presence of MS was an independent determinant of LVH ( Table 2) . Because there is a collinearity between sleep-trough morning SBP increase and nocturnal SBP decline (r = −0.53; P < 0.001), and between sleep-trough morning SBP increase and 24-h SBP variability (r = 0.23, P = 0.001), we reanalyzed our data after the deletion of one of the variables; the conclusion was the same (see Supplementary Table S2 online). Moreover, a separate analysis in Table 2 with MS risk as a continuous variable showed that a 10-mm Hg increase in sleep-trough morning SBP increase was also significantly associated with LVH (OR: 1.41; 95% CI: 1.11-1.79; P < 0.01).
carotid ultrasonography
The ICA-IMT level was significantly greater in the MS group compared with the non-MS group after adjustment for daytime SBP variability, the degree of nocturnal BP decline, the plasma LDL level, and the use of diuretics (1.28 ± 0.47 mm vs. 1.16 ± 0.37 mm; P < 0.01). In contrast, there was no significant difference in the level of CCA-IMT between the two groups. A multiple logistic regression analysis revealed that the presence of MS was an independent determinant of the highest quartile of ICA-IMT (Table 3 and see Supplementary  Table S3 online) . A separate analysis in Table 3 with MS risk as a continuous variable showed that a 10-mm Hg increase in sleep-trough morning SBP increase was an independent determinant of high ICA-IMT (OR: 1.36; 95% CI: 1.05-1.77; P < 0.05).
mS risk of patients with a well-controlled 24-h BP level
In this study, there were 75 patients (38%) with a wellcontrolled 24-h BP level (<130/80 mm Hg). Even in the patients, the MS group (n = 17) had a significantly higher level of LVMI and ICA-IMT than the non-MS group even after adjustment for daytime SBP variability, the degree of nocturnal BP decline, the plasma LDL level, and the use of diuretics (LVMI: 120.9 ± 33.3 g/m 2 vs. 103.6 ± 20.2 g/m 2 , P < 0.01; ICA-IMT: 1.40 ± 0.55 mm vs. 1.13 ± 0.36 mm, P < 0.05).
waking mS
We also examined the MS risk by defining it as waking MS. In Table 2 , when we examined the waking MS risk (the highest quartile of waking morning SBP increase: ≥44 mm Hg) instead of the sleep-trough MS, waking MS was not significantly associated with LVH (OR: 2.03; 95% CI: 0.90-4.56; P = 0.09); however, it remained significantly associated with high ICA-IMT (OR: 2.68; 95% CI: 1.06-6.73; P < 0.05).
relationship between nocturnal BP dipping status and mS
The prevalence of extreme dippers, dippers, nondippers, and risers was 43% (n = 21), 45% (n = 22), 10% (n = 5), and 2% (n = 1), respectively, in the MS group, and 13% (n = 19), 40% (n = 60), 31% (n = 46), and 16% (n = 23) in the non-MS group. The prevalence of each category was significantly different between the two groups (P < 0.001). Among the extreme dippers (n = 40), 54% were classified into the MS group. As a whole, the levels of LVH and IMT in extreme dippers were not significantly different compared with those in the dipper group (data not shown). However, there was a significant difference This cross-sectional study is the first report to show significant associations between MS and cardiovascular remodeling, independent of 24-h BP level, daytime BP variability, and nocturnal BP decline in ambulatory treated elderly hypertensives. This finding is novel, because all previous studies to show the cardiovascular risk of MS were derived from a general population or untreated or partly treated hypertensives. [1] [2] [3] [4] [5] [6] [7] [8] These findings were also seen even in those with a well-controlled 24-h BP level. Our findings strengthen the idea that MS is applicable for the clinical assessment of hypertension, and corroborate the perspective that MS during administration of antihypertensive medications is an independent risk factor for cardiovascular remodeling.
the characteristics of mS
The use of diuretics was more frequent in the MS group than the non-MS group, despite that there were no significant differences in the mean number of antihypertensive medications and 24-h BP level between the groups. Diuretic therapy, an optimal antihypertensive therapy to reduce cardiovascular disease-related morbidity and mortality, 13 has been shown to be capable of enhancing nocturnal BP fall and thereby influence the extent of sleep-trough morning SBP increase. 14 In our study, the levels of nocturnal BP and dipping status were similar between subjects who were and those who were not taking diuretics (data not shown), suggesting at least that the use of diuretics could not suppress the postwaking BP elevation in our elderly hypertensives. This may have been related to the fact that diuretic administration tended to increase sympathetic activity, 15 which exerts an important pathophysiological effect on postwaking BP elevation. 16 However, our study had a small sample size and was not an interventional survey, but rather a study designed to examine a hypothesis, and thus further investigations will be needed to examine this possibility.
cardiac remodeling in mS
This study strengthened our previous reports 2 that MS group had significantly higher levels of cardiac hypertrophy compared with non-MS group in subjects being treated with antihypertensive medications. That the risk posed by MS remained significant even in subjects with a well-controlled 24-h BP level (<130/80 mm Hg) confirmed that MS is significantly associated with cardiovascular remodeling independently of the status of BP control under treatment.
In contrast to sleep-trough MS, waking MS was not associated with LVH. This means that LVH was more strongly correlated with exaggerated BP change, and corroborates the previous finding that erratic BP variability (occurring regularly from nocturnal to awake) rather than 24-h BP variability contributes to LVH. 17 Furthermore, the finding that neither awake nor nocturnal BP variability affected our results strengthens the perspective that a time-specific component of BP variation, particularly one occurring over the 2 h after waking from sleep, could be the most important factor in cardiac hypertrophy among treated hypertensives.
Although there was a significant inverse association between MS and less nocturnal BP decline, both para meters were independently associated with cardiovascular remodeling (Tables 2 and 3) . This means that MS and less nocturnal BP decline could be jointly associated with cardiovascular remodeling in treated elderly hypertensives, although our cross-sectional data are not sufficient to distinguish such a cause-effect relationship.
carotid artery remodeling in mS
In line with previous reports, 7, 8 MS was associated with carotid artery remodeling independent of 24-h BP level and BP variability. Our data showed that a higher level of only ICA-IMT, including measurement at the level of the bulb, but not a higher level of CCA-IMT, was significantly associated with MS. This is not surprising, because a segment-specific effect of cardiovascular risk factors on carotid artery remodeling has been reported. 18, 19, 20 When MS was defined by waking MS, it was also significantly associated with carotid artery remodeling. Baroreceptor sensitivity and endothelial function are prone to be reduced in the morning, 21 and thus the greatest rate of BP variability occurs in the morning. 7 Therefore, the impact of BP variability and its rate on cardiovascular risk may be more markedly enhanced during the morning hours than in other periods. 7 However, increased arterial stiffness, which is a reflection of the progression of IMT, may account for the greater BP change during the morning hours, because stiffer and less compliant vessels can be less buffering of BP changes, resulting in a wider BP oscillation for any given change in the stroke volume. Such articles Cardiovascular Risk of Morning BP Surge a cause-effect relationship cannot be inferred from the results of this study. Our study has several limitations. First, a cause-effect relationship between MS and cardiovascular remodeling cannot be inferred from our cross-sectional data. Second, all parameters, such as ABPM, cardiac and carotid ultrasonography, and laboratory data, were measured only once. In particular, there has been extensive criticism for the lack of the reproducibility of MS, 22 although the available evidence showing the clinical value of MS has been based entirely on a single recording of 24-h ambulatory BP. [1] [2] [3] [4] [5] [6] [7] [8] In conclusion, our study has strengthened the idea that in addition to 24-h SBP level and the extent of nocturnal SBP decline, which are already established factors for cardiovascular remodeling in elderly hypertensive patients, 10, 17, 23 MS in patients taking antihypertensive medications could also be associated with cardiovascular remodeling, independently of 24-h BP levels, daytime BP variability, and nocturnal BP decline. Further prospective studies are needed to assess whether MS among treated hypertensive subjects predicts the incidence of cardiovascular diseases, and whether therapy aimed at improving sleep-trough MS may have a favorable effect on a patient's prognosis.
